Dual Delayed-Release Dexlansoprazole for Healing and Maintenance of Healed Erosive Esophagitis: A Safety Study in Adolescents.

Dig Dis Sci · 2019 · PMC6514063 · PMID 30390234

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The numeric differences in EE healing rates between dexlansoprazole and placebo were notable but did not reach statistical significance; 58% of adolescent patients in the present study maintained EE healing with placebo, while in the adult study only 14% had remained healed with placebo treatment [ 22 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.